Market Intelligence for CDMOs: Turning Market Complexity into Commercial Growth 

The challenge of navigating rapidly evolving markets

For today’s CDMOs, winning new business has become increasingly complex.

Therapeutic innovation, new modalities and emerging biotech companies are creating opportunities for CDMOs, but also making it harder to see where demand is emerging, which companies need support and how best to engage them.

A CDMO evaluating expansion into a new modality needs to know which companies are advancing relevant assets, which are most likely to outsource development or manufacturing activities, and which factors influence partner-selection decisions. Linking those answers together allows commercial teams to focus efforts on the highest-value opportunities

As a result, many CDMOs risk investing business development resources in the wrong markets, pursuing low-probability opportunities or missing high-value customers altogether.

The challenge is rarely a lack of information. Most organizations already have access to market reports, CRM systems and conference intelligence. The challenge is connecting these information sources into a clear view of where to focus commercial effort.

This is where a structured market and customer intelligence strategy can create a meaningful competitive advantage.

By combining proprietary life science data, scientific expertise and strategic consulting, Beacon helps CDMOs understand evolving markets, identify the right opportunities and develop customer engagement strategies that drive growth.

1. Understand where demand is emerging

Need: To capture future business, CDMOs must first understand where future demand is likely to arise.

This means monitoring therapeutic, technological and commercial developments across a diverse and rapidly evolving life sciences landscape. Emerging modalities, changing funding patterns, clinical progression and shifts in outsourcing behaviour can all influence future demand for development and manufacturing services.

Organizations that rely solely on historical customer relationships or reactive business development risk missing high-growth opportunities before competitors identify them.

Solution: Beacon helps organizations build a forward-looking view of the market through integrated life science intelligence and strategic analysis. By tracking assets, companies, clinical activity, investment trends, manufacturing requirements and technology adoption across multiple modalities, CDMOs can gain earlier visibility into markets where outsourcing demand is likely to emerge. Importantly, this is not simply about monitoring activity. Combining Beacon’s data assets with Beacon Consulting’s scientific and commercial expertise allows organizations to understand which developments are most likely to translate into future business opportunities, and which signals can safely be deprioritized.

Impact: A clearer view of future demand helps CDMOs align capacity, capabilities and business development with promising markets, then engage prospective customers before opportunities become widely recognized.

2. Identify and prioritize the right opportunities

Need: Even when attractive markets have been identified, commercial teams often find it challenging to determine which companies should be prioritized. Most CDMOs operate in markets containing hundreds or even thousands of potential customers. Attempting to pursue every opportunity can dilute resources, reduce efficiency and limit commercial impact. The ability to systematically identify and prioritize the highest-value targets is therefore becoming a critical business development capability.

Solution: Beacon’s Partner Scanner methodology was designed to use market evidence to transform a large and often unmanageable target universe into a focused list of high-potential opportunities supported by a transparent rationale. Companies can be prioritized according to factors such as:

  • Modality alignment
  • Development stage
  • Outsourcing potential
  • Funding status
  • Geographic footprint
  • Therapeutic focus
  • Strategic fit with existing capabilities.

Impact: Commercial teams gain greater confidence in where to invest their time and resources.

The result is a more focused pipeline, higher-quality customer conversations and a business development strategy centred on opportunities most likely to generate long-term revenue. Prioritization also becomes a repeatable process rather than a subjective exercise, allowing organizations to adapt quickly as markets evolve.

3. Understand how customers choose partners

Need: CDMOs must also understand how prospective customers evaluate potential partners and what factors influence vendor selection decisions. Technical capability remains important, but customer decisions are increasingly shaped by considerations such as flexibility, responsiveness, scientific expertise, previous experience, geographic presence, communication quality and perceived risk. Organizations that fail to understand these decision drivers risk losing opportunities despite having competitive capabilities.

Solution: Beacon Consulting combines customer research, competitive intelligence and market context to uncover the factors that shape purchasing decisions. Through direct engagement with customers and industry stakeholders, organizations can gain a clearer understanding of:

  • How customers evaluate CDMO partners
  • The attributes buyers value most
  • Common barriers to vendor selection
  • Competitor strengths and weaknesses
  • Unmet needs within target customer segments

Beacon Consulting can translate these findings into stronger value propositions, more compelling commercial messaging and clearer evidence-based proof points for customer engagement. Rather than relying on assumptions about what customers value, commercial teams can develop communications and engagement strategies grounded in real market feedback.

Impact: Better customer understanding leads to more effective business development. Commercial teams can tailor conversations to address customer priorities, strengthen competitive positioning and improve the quality of customer interactions. The result is a more differentiated market presence and a greater likelihood of progressing opportunities through the commercial pipeline. In increasingly competitive markets, the quality and relevance of initial customer engagement can significantly influence long-term commercial outcomes.

Turning intelligence into commercial advantage

The most successful CDMOs increasingly recognize that market understanding, opportunity prioritization and customer engagement cannot be treated as separate activities.

  • Market intelligence provides visibility into future demand.
  • Opportunity prioritization identifies the organizations most likely to require support.
  • Customer insight ensures commercial teams engage those organizations with relevant, evidence-based messages that address real selection criteria.

Together, these disciplines create a connected commercial intelligence framework that links market opportunity, customer prioritization and engagement strategy.

Beacon Consulting helps CDMOs understand exactly how prospective customers evaluate outsourcing partners, enabling teams to refine positioning, strengthen value propositions and improve the effectiveness of early commercial conversations.

CDMOs that spot emerging opportunities, focus on the right customers and demonstrate relevant value will be better placed to compete, regardless of team size or service breadth.

Get in touch:

Get in touch to discuss how, by combining market intelligence with customer insight, Beacon Consulting helps organizations turn complex markets into actionable growth opportunities.

Learn More About Consulting

What is Beacon Consulting?
  • We are specialist life sciences market research and consultants, delivering tailored insights across the full drug development and commercialisation lifecycle.
  • Combines scientific expertise, expert networks, and proprietary Beacon data to transform complex data into clear, strategic decisions.
  • Provides fully customised research, spanning qualitative interviews, quantitative analysis, and desk research, aligned to your specific business objectives.
  • Helps biopharma teams reduce risk, identify opportunities, and accelerate decision-making with actionable, decision-ready insights.
Learn More About Beacon Consulting

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search